Skip to main content
Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Expression of the amyloid-β peptide in a single pair of C. elegans sensory neurons modulates the associated behavioural response

  • Tessa Sinnige,

    Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Writing – original draft, Writing – review & editing

    Affiliation Centre for Misfolding Diseases, Department of Chemistry, University of Cambridge, Cambridge, United Kingdom

  • Prashanth Ciryam,

    Roles Data curation, Formal analysis, Methodology, Writing – review & editing

    Affiliation Centre for Misfolding Diseases, Department of Chemistry, University of Cambridge, Cambridge, United Kingdom

  • Samuel Casford,

    Roles Data curation, Formal analysis, Writing – review & editing

    Affiliation Centre for Misfolding Diseases, Department of Chemistry, University of Cambridge, Cambridge, United Kingdom

  • Christopher M. Dobson,

    Roles Conceptualization, Formal analysis, Funding acquisition, Project administration, Supervision, Writing – original draft, Writing – review & editing

    Affiliation Centre for Misfolding Diseases, Department of Chemistry, University of Cambridge, Cambridge, United Kingdom

  • Mario de Bono,

    Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Supervision, Validation, Writing – original draft, Writing – review & editing

    Affiliation Cell Biology Division, Medical Research Council Laboratory of Molecular Biology, Cambridge, United Kingdom

  • Michele Vendruscolo

    Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Supervision, Validation, Writing – original draft, Writing – review & editing

    Affiliation Centre for Misfolding Diseases, Department of Chemistry, University of Cambridge, Cambridge, United Kingdom


Although the aggregation of the amyloid-β peptide (Aβ) into amyloid fibrils is a well-established hallmark of Alzheimer’s disease, the complex mechanisms linking this process to neurodegeneration are still incompletely understood. The nematode worm C. elegans is a valuable model organism through which to study these mechanisms because of its simple nervous system and its relatively short lifespan. Standard Aβ-based C. elegans models of Alzheimer’s disease are designed to study the toxic effects of the overexpression of Aβ in the muscle or nervous systems. However, the wide variety of effects associated with the tissue-level overexpression of Aβ makes it difficult to single out and study specific cellular mechanisms related to the onset of Alzheimer’s disease. Here, to better understand how to investigate the early events affecting neuronal signalling, we created a C. elegans model expressing Aβ42, the 42-residue form of Aβ, from a single-copy gene insertion in just one pair of glutamatergic sensory neurons, the BAG neurons. In behavioural assays, we found that the Aβ42-expressing animals displayed a subtle modulation of the response to CO2, compared to controls. Ca2+ imaging revealed that the BAG neurons in young Aβ42-expressing nematodes were activated more strongly than in control animals, and that neuronal activation remained intact until old age. Taken together, our results suggest that Aβ42-expression in this very subtle model of AD is sufficient to modulate the behavioural response but not strong enough to generate significant neurotoxicity, suggesting that slightly more aggressive perturbations will enable effectively studies of the links between the modulation of a physiological response and its associated neurotoxicity.


Protein misfolding and aggregation is a phenomenon associated with a wide variety of neurodegenerative disorders [14]. In particular, in Alzheimer’s disease (AD), the most common form of dementia, amyloid-β (Aβ) and tau form characteristic deposits known as amyloid plaques and neurofibrillary tangles, respectively [5]. To understand the molecular origins of this disease, and to allow its timely diagnosis and effective treatment, it is of great importance to establish which are the mechanisms responsible for its onset and progression [6,7]. Recent evidence suggests that the appearance of amyloid plaques may precede the onset of disease symptoms by many years [810], and that soluble oligomeric Aβ species, rather than mature fibrils, confer the toxicity initiating synaptic dysfunction early in the disease process [1113]. However, much remains unclear about the molecular mechanisms underlying the disease process, and no effective therapeutics are currently available.

The nematode C. elegans is a well-characterised model organism with a simple nervous system comprising 302 neurons, the connectivity of which has been fully determined [14]. C. elegans has a homologue of the human amyloid precursor protein (APP) from which the Aβ peptide is derived, but the corresponding gene (apl-1) does not encode for the human Aβ sequence [15]. Previously, Aβ-based C. elegans models of AD have been generated in which the human form of Aβ is overexpressed in body-wall muscle cells, leading to the formation of amyloid deposits and progressive paralysis of the worms within several days of adulthood [16,17]. Although muscle cell expression and motility phenotypes provide powerful readouts to screen for genes [18,19] or small molecules [20,21] affecting the Aβ aggregation process, neuron-specific models are particularly useful to obtain insights into the exact mechanisms linking the properties of Aβ to neurodegeneration. A strain of C. elegans has been generated with pan-neuronal overexpression of Aβ, and toxicity was inferred from defects in chemotaxis and learning, as well as a reduction in lifespan [22,23]. In another model Aβ was overexpressed in glutamatergic neurons, which comprise more than a third of all C. elegans neurons. Glutamatergic tail neurons were then inspected for signs of neurodegeneration to validate hits from a yeast genetic screen [24]. Furthermore, Cotella et al. overexpressed an Aβ construct in ASE neurons and observed chemotaxis defects [25].

In the current study, we took a different approach from traditional overexpression models, and designed a C. elegans model to investigate possible strategies for the assessment of the early events associated with Aβ expression at the single-neuron level. To accomplish this aim, we expressed the 42-residue form of human Aβ (Aβ42), the predominant component of amyloid plaques in humans, from a single-copy gene insertion in only two sensory neurons. This strategy results in more moderate expression levels than traditional plasmid overexpression, which leads to the generation of an extrachromosomal array that may contain over a 100 gene copies [26]. We chose the pair of BAG neurons, since they are glutamatergic and are thus among the neuron types most vulnerable to AD in the human brain [2730]. The BAG neurons are tonically activated—another feature in common with human neurons vulnerable to AD [31]—by elevated concentrations of CO2 as well as hypoxia, and activation is linked to behavioural changes in speed and direction of travel through relatively well-understood signalling pathways [3236]. As such, we reasoned that expression in the BAG neurons would provide clear readouts to examine Aβ42-mediated changes in neuronal function.

Materials and methods

C. elegans strains

Nematodes were maintained on nematode growth media (NGM) plates seeded with Escherichia coli OP50 at 20°C, unless stated otherwise. Strain EG6699 was maintained on NGM plates seeded with E. coli HB101 at 15°C. For age-dependent studies, a synchronized worm population was generated by a 4 h synchronized egg-lay at 20°C, after which incubation was continued at 25°C throughout the experiment unless stated otherwise.

The strains of C. elegans used in this study include:

N2 (Bristol)

EG6699 ttTi5605 II; unc-119(ed3) III; oxEx1578([eft-3p::GFP + Cbr-unc-119]

AX204 npr-1(ad609) X

AX6171 npr-1(ad609) dbEx[pflp-17::Aβ1–42::unc54 3’ UTR + ccRFP]

CMD01 ttTi5605 camIs[pflp-17::Aβ1–42::SL2mCherry::let-858 3’ UTR + Cbr-unc-119] II; unc-119(ed3) III

CMD06 ttTi5605 camIs[pflp-17::mCherry::let-858 3’UTR + Cbr-unc-119] II; unc-119(ed3) III

AX2073 dbEx[pflp-17::YC3.60]

CMD12 ttTi5605 camIs[pflp-17::Aβ1–42::SL2mCherry::let-858 3’UTR + Cbr-unc-119] II; unc-119(ed3) III; dbEx[pflp-17::YC3.60]

CMD13 ttTi5605 camIs[pflp-17::mCherry::let-858 3’UTR + Cbr-unc-119] II; unc-119(ed3) III; dbEx[pflp-17::YC3.60]

CL2355 smg-1(cc546) dvIs50 [pCL45 (snb-1::Aβ 1–42::3' UTR(long) + mtl-2::GFP]

GMC101 dvIs100 [unc-54p::Aβ 1–42::unc-54 3'-UTR + mtl-2p::GFP]

DNA cloning

DNA constructs were created using MultiSite Gateway Cloning (Thermo Fisher Scientific). As a promoter sequence, we used 2 kb upstream of flp-17 in position 1. The sequence for human Aβ42 preceded by a signal peptide, as used previously [17], was codon-optimized for C. elegans using Jcat [37], and synthesized by GeneArt (Thermo Fischer Scientific). This construct was cloned into position 2, and the SL2::mCherry sequence in position 3. The 3’ UTR region of let-858 was inserted into the backbone of pCFJ150 [38] in which the full construct was assembled. For the control line, mCherry was inserted in Gateway position 2 and the let-858 3’ UTR in position 3, followed by assembly into pCFJ150. For overexpression of Aβ42, the 3’ UTR of unc-54 was inserted into gateway position 3, and the construct with pflp-17 in position 1 and Aβ42 with signal peptide in position 2 was assembled into pDEST. The constructs were verified by Sanger sequencing.

Creation of transgenic strains

Strains were generated by Mos-1 single copy insertion following published protocols [38], by micro-injection of plasmid DNA into the gonads of young adults of strain EG6699. Mos-1 insertions were verified by PCR with LongAmp Taq polymerase (New England Biolabs) followed by Sanger sequencing. The Aβ42 plasmid for overexpression was micro-injected into the gonads of young adults of strain AX204 together with a plasmid encoding cc::RFP, and transgenic offspring was selected based on RFP expression in the coelomocytes.

Antibody staining and imaging

Animals were fixed at day 3 of adulthood in 4% formaldehyde in PBS for 24 hours at 4°C, followed by β-mercaptoethanol and collagenase treatment to digest the cuticle, as described previously [39,40]. Fixed and permeabilised animals were probed with anti-amyloid-β antibody 4G8 (epitope residues 17–24), followed by Alexa-488 conjugated anti-mouse secondary antibody (both obtained from Biolegend UK Ltd). Stained animals were mounted in ProLong Gold antifade reagent with DAPI (Life Technologies) and imaged on a Leica SP8 confocal microscope using a 63x water immersion objective. To visualize the BAG neurons in living animals, the nematodes were anaesthetized with sodium azide and mounted on an agarose pad. Imaging was performed on an Andor Revolution spinning disk microscope with a 20x objective and a Leica SP8 confocal microscope using a 40x oil or a 63x oil objective.

Lifespan assay

For lifespan assays, 150 nematodes per strain derived from a 4 h synchronized egg-lay were placed on 3 cm NGM plates containing 75 μM 5-fluoro-2’-deoxyuridine (FUDR, Sigma) at the L4 stage, and incubated at 25°C. In an independent experiment, FUDR was omitted and the nematodes were transferred daily to fresh plates during their reproductive phase. The worms were counted daily and scored as dead when they did not respond to gentle prodding with a platinum wire. Worms that crawled up against the side of the plate were excluded from the analysis. The lifespan assays were scored blindly.

Motility assay

The motility assay was performed as described previously [41]. In brief, an age-synchronised population of animals was generated by bleaching, and worms were transferred to NGM plates containing 75 μM FUDR (Sigma) at L4 stage and incubated at 25°C. The motility assay was performed on ca. 500 animals for each strain and timepoint, and body bends per minute were determined using custom-written software.

Behavioural assays

For behavioural assays, worms were grown on NGM plates either at room temperature (20–22°C) or at 25°C. CO2 conditioning was performed by raising the animals in a chamber filled with 21% O2 + 3% CO2 starting after a synchronised egg-lay. Assays on aged nematodes were performed by daily transfer to fresh NGM plates to separate the adults from their offspring. Naïve animals from the same batch that were not previously assayed were used for each time point, and at least three independent experiments were performed for each of the assays. For the CO2 assay, NGM plates were seeded with 20 μL of an overnight culture of E. coli OP50 approximately 20 hours before the assay. For each assay, 20 nematodes were placed onto the resulting food lawn and a 1 cm × 1cm × 200 μm polydimethylsiloxane (PDMS) chamber was placed on the plate, with gas inlets connected to a PHD 2000 Infusion syringe pump (Harvard Apparatus) as described previously [35]. The animals were allowed to adjust for several minutes before the start of the assay, followed by exposure to a 1.5 mL/min gas flow consisting of 21% O2 for 3 min, 21% O2 + 3% CO2 for 3 min, and finally 21% O2 for 3 min. For the assays of npr-1 animals, the gases used were 7% O2 for 3 min, 7% O2 + 3% CO2 for 3 min, and 7% O2 for 3 min. Videos were recorded using FlyCapture on a Leica M165FC microscope with a Point Gray Grasshopper camera at 2 frames per second. The hypoxia assay was performed on animals starved for 4–6 h, and transferred to unseeded 3 cm NGM plates sealed with a copper ring to contain the worms within the field of view of the camera. The gas flow was applied using a custom-made setup at approximately 1–1.5 mL/min with 21% O2 for 6 min, 7% O2 for 6 min, and 21% O2 for 6 min. Videos were recorded using Dino-Lite Digital Microscope cameras at either 6 or 10 frames per second. Custom-written Matlab software was used to track the nematodes and to determine the fraction making omega turns, reversals and speed [35].

Ca2+ imaging

Aβ42 and mCherry control lines were crossed with strain AX2073 expressing Ca2+ sensor YC3.60 [42] under the flp-17 promoter, driving expression in BAG. The assay was performed on freely moving animals using the set-up described previously [43]. Individual animals were placed on 5 cm agarose plates (17 g/L agarose, 3 g/L NaCl, 5 mg/L cholesterol, 1 mM MgSO4, 1 mM CaCl2) seeded with a 3 μL concentrated drop of E. coli OP50. A PDMS chamber was placed on top and the gases were applied at 1.4 mL/min, with 21% O2 for 2 min, 21% O2 + 3% CO2 for 2 min, and finally 21% O2 for 2 min.

Videos were recorded at 10 frames per second using 100 ms exposure time on a Nikon AZ100 microscope with an AZ Plan Fluor 2x lens. A TwinCam adaptor (Cairn Research, UK) and two ORCA-Flash4.0 V2 digital cameras (Hamamatsu, Japan) were used to simultaneously record YFP and CFP fluorescence. The neurons were tracked and the YFP/CFP ratios (R) calculated using custom-written Matlab software. R0 was defined as the initial value averaged over the first 100 frames (10 s) and ΔR/R0 expressed as the percentage increase.

X-34 staining

Animals were grown at 25°C until day 7 of adulthood, washed in M9 buffer and incubated in 1 mM X-34 (Sigma) in 10 mM Tris-HCl pH 8.0 at room temperature for 3 h. They were then transferred to seeded NGM plates and allowed to destain for ca. 16 h. Imaging of anaesthetised animals was performed as described above on a Leica SP8 with 63x oil objective.


A Mann-Whitney U-test was applied for statistical analysis of the omega turn response over the time intervals as indicated in the figures. A t-test was used to examine speed, unless the data were not normally distributed in which case the Mann-Whitney U-test was applied. Ca2+ levels were assessed with a t-test over the interval of interest. The data were considered statistically significant at p < 0.05.

Results and discussion

A C. elegans model expressing Aβ42 in the two BAG neurons (BAG-Aβ worms)

We designed a construct encoding human Aβ42 (codon-optimized for C. elegans) targeted to the secretory pathway by a signal peptide, an approach which was previously employed for Aβ overexpression lines and results in the 42-residue Aβ peptide after cleavage of the signal sequence [17]. We used the flp-17 promoter to induce robust expression exclusively in the pair of BAG neurons. As a marker for expression, we incorporated mCherry after an SL2 trans-splice site, making an operon that separately expresses cytoplasmic mCherry. To ensure reproducible expression at relatively low levels, we generated integrated lines using Mos1 single copy insertion (Fig 1A) [38].

Fig 1. Construction of a C. elegans model that expresses Aβ42 in the two BAG neurons.

(A) Design of the construct for Mos1 insertion. (B) Confocal image of the Aβ42 strain showing mCherry expression in the BAG neurons. (C) Staining with the 4G8 anti-Aβ (17–24) antibody (green), which shows that Aβ is localized primarily around the nuclei (visualized by DAPI staining, blue). In some cases, weak staining was observed in a region that may correspond to the BAG axons (white arrows). (D) Lifespan assay. The worms were scored daily in response to gentle prodding with a platinum wire, and the number of animals that remained alive was plotted as a fraction of the number of L4 worms at the start of the experiment. The assay was performed in a blinded fashion and two independent experiments showed no difference in lifespan between Aβ42 and control strains. (E) Motility assay. Body bends per minute are plotted for BAG-Aβ and control strains, averaged over two independent experiments. Error bars indicate standard error of the mean.

We observed mCherry expression throughout the BAG neurons (Fig 1B), whereas antibody staining indicated that the expressed Aβ42 mainly resided intracellularly, being visible surrounding the nucleus (Fig 1C). Although our Aβ42 construct comprises a signal sequence that was originally designed for secretion [16], it has been demonstrated previously that cleaved Aβ42 accumulates intracellularly when expressed in body wall muscle cells, and our findings are thus in line with the suggestion that Aβ42 may be unable to exit the secretory system in these models [16,44].

In addition, we generated a control line expressing only cytoplasmic mCherry in the BAG neurons, and performed life span assays to characterise the model when grown at 25°C, the temperature that was previously shown to maximise toxicity in a strain overexpressing Aβ42 in the body wall muscle cells [17]. We found that the lifespan of both strains was virtually identical with a median of 10.9 days for the animals expressing Aβ42, compared to 10.8 days for the control animals (Fig 1D). In a motility assay, the BAG-Aβ worms did not show impairments either compared to control animals throughout their lifespan (Fig 1E). These results indicate that Aβ42 expression in the BAG neurons did not cause widespread toxic effects in our model, in contrast to the reduced lifespan reported for a strain with pan-neuronal Aβ42 overexpression [23] and the strong paralysis observed for the muscle model [17].

Modulation of the behavioural response of the BAG-Aβ worms

We then set out to examine the effects of Aβ42 on the function of the BAG neurons using behavioural assays. The BAG neurons mediate C. elegans avoidance of elevated concentrations of CO2, via a transmembrane guanylate cyclase which signals opening of the TAX-2/TAX-4 cGMP-gated ion channel [33,34]. At the behavioural level, BAG activation induces characteristic omega-shaped turns of the animals in response to a CO2 stimulus. In the behavioural assay, animals were allowed to crawl on a seeded nematode growth media (NGM) plate, and covered by a microfluidic chamber to which the desired gas mixtures were applied [35]. We used a custom-written software to track the worms and automatically determine their speed and turning, as described previously [35]. In this assay, we observed a reduction in the fraction of Aβ42 animals making omega turns with respect to controls, whereas speed was unaffected (Fig 2A). We confirmed that this phenotype was associated with Aβ42-expression, rather than resulting from an undesired mutation that may have occurred while creating the transgenic strain, in an independent experiment on animals overexpressing Aβ42 in BAG. This strain was created in an npr-1 mutant background which requires the CO2 assay to be performed at 7% O2, and we observed that also under these conditions Aβ42-expression was associated with a reduction in omega turns (S1 Fig). In contrast, subjecting the strain overexpressing Aβ throughout the nervous system [22] to the CO2 assay resulted in a different phenotype. L4 animals were incubated at 25°C overnight prior to the assay which is required to induce Aβ expression in this model, and the assayed adults showed a prolonged period of omega turns and a strong reduction in overall speed compared to wild-type N2 worms treated in the same way (Fig 2B). This phenotype is likely caused by several types of neurons being affected by Aβ-overexpression in this strain, including interneurons and motor neurons, demonstrating the importance of neuron-specific expression to examine BAG-related behavioural changes.

Fig 2. CO2 assay of Aβ-expressing strains.

(A) Fraction of omega turns (top) and speed (bottom) of BAG-Aβ worms (red, n = 221) and mCherry controls (blue, n = 228) in response to 3% CO2. (B) CO2 assay of strain CL2355 with panneuronal Aβ-overexpression (red, n = 172) and N2 controls (blue, n = 170). Statistical tests were performed with a Mann-Whitney U-test, **** p < 0.0001.

To further characterise the behavioural phenotype of the BAG-Aβ worms, we employed another assay that depends on BAG function, in which starved animals respond to a decrease in oxygen concentration by reducing their speed [45] (Fig 3). We observed that BAG-Aβ and control animals similarly slowed down (Fig 3A) and increased their reversals (Fig 3B) upon a downshift of 21% to 7% O2, both of which responses were previously shown to be abolished in BAG-ablated animals [45]. Furthermore, we found a peak in the fraction of animals making omega turns when the concentration was upshifted from 7% to 21% O2. Although the maximum omega turn response in the Aβ-expressing worms remained below that of the controls, this effect did not reach statistical significance (Fig 3C).

Fig 3. Hypoxia assay of starved BAG-Aβ and mCherry control animals.

(A) Speed response, (B) reversal propensity, and (C) fraction of omega turns of BAG-Aβ (red, n = 201) and control (blue, n = 209) animals in response to a downshift from 21% to 7% O2 and upshift back to 21% O2.

Next, we were interested in exploring the effects of Aβ42 expression on BAG-dependent learning and memory. The BAG neurons were recently shown to mediate experience-dependent changes in chemotaxis behaviour towards CO2 [46]. When we raised the nematodes at an elevated CO2 concentration of 3%, we observed in our CO2 assay that control animals did not change their omega turn propensity (Fig 4A, left), but had a steeper decrease in speed after removal of the CO2 stimulus (Fig 4A, right). In BAG-Aβ worms, on the other hand, the fraction of omega turns was increased upon CO2 conditioning (Fig 4B, left), suggesting they had become sensitised. The modulation of the speed decline after the stimulus was similar to that of controls (compare right panels of Fig 4B and Fig 4A), indicating that Aβ42 expression did not abolish experience-dependent modulation of the behavioural response.

Fig 4. Experience-dependent modulation of the CO2 response.

Behavioural response of (A) control animals raised at ambient atmosphere (blue, n = 228) or at 3% CO2 (black, n = 216), (B) BAG-Aβ animals raised at ambient atmosphere (red, n = 221) or or at 3% CO2 (grey, n = 215). Omega turns were assessed using a Mann-Whitney U-test and speed with a t-test over the indicated intervals. **** p < 0.0001.

Behavioural response, but not neuronal activation, declines with age

We continued to examine the effects of ageing on the Aβ42-associated phenotype in our neuron-specific model by assaying the animals at day 1, 2 and day 3 of adulthood, when raised at 25°C (Fig 5). We found that the difference between Aβ42 and control animals in response to CO2 did not increase with age, and that omega turns in both lines strongly declined with age (Fig 5). A similar trend with age was observed for animals raised at 20°C, as well as for the N2 wild-type laboratory strain, indicating that this effect was not caused by mCherry expression or by the elevated growth temperature (S2 Fig).

Fig 5. Locomotory responses to 3% CO2 as a function of ageing.

Shown are the fraction of animals making omega turns (upper panels) and the modulation of speed (lower panels) in response to a 3% CO2 stimulus (shaded in blue) at day 1 (A), day 2 (B) and day 3 (C) of adulthood. For each time point, naïve animals not previously assayed were taken from the same batch of animals. The data shown here were averaged over multiple independent experiments, Aβ n = 220–280, control n = 160–241. Statistics on the fraction of omega turns were performed with a Mann-Whitney U-test over the indicated time intervals. * p < 0.05, ** p < 0.01, NS not significant.

By contrast, the typical BAG-mediated ‘off-response’, observed as a transient increase in speed directly after switching off the CO2 stimulus [36], remained intact at all ages examined (Fig 5 and S2 Fig lower panels). We did not, however, observe a consistent difference between Aβ42 and control animals using speed as a read-out. The use of this parameter was furthermore limited due to the age-associated overall reduction in speed, which may reflect muscle decline rather than neuronal malfunction [47].

We next turned to Ca2+ imaging as a way to directly assess the response of the BAG neurons. The Förster resonance energy transfer (FRET) sensor YC3.60 [42] was expressed in the BAG neurons, and we monitored the increase in intracellular Ca2+ concentration upon activation with 3% CO2 (Fig 6). We found that there was a significantly elevated Ca2+ response in young Aβ42-expressing worms compared to controls (day 1 p = 0.04, day 3 p = 0.03) (Fig 6A and 6B), and that this difference disappeared in older animals (Fig 6C–6E). Furthermore, we found that the CO2-evoked Ca2+ response in BAG remained intact as the animals aged, showing no signs of impairment as a result of Aβ42 expression or age-related effects. Even at day 12, beyond the median lifespan of 11 days, the Ca2+ response was preserved (Fig 6E), suggesting that the BAG neurons remain functional at least at the level of Ca2+ activation throughout the lifespan of C. elegans.

Fig 6. Ca2+ response in the Aβ-BAG worms and corresponding controls.

(A) Day 1 of adulthood, (B) day 3, (C) day 6, (D) day 9, (E) day 12. For each measurement, naïve animals not previously exposed to elevated CO2 levels were taken from the same batch of age-synchronised animals. Data were averaged over 2–4 biological replicates for each time point, n = 23–28 per strain for day 1, 3, 6, 9 and n = 11–13 for day 12. ΔR/R0 represents the percent increase in YFP/CFP ratio, normalized to the baseline value. Statistics were performed using a t-test between 160 s and 200 s, * p < 0.05.

Consistent with the modest phenotype of the BAG-Aβ42 worms, and the absence of neurodegeneration as judged from the Ca2+ response, we failed to detect amyloid deposits using the amyloid-binding dye X-34 (Fig 7). However, the presence of soluble oligomeric species cannot be ruled out and may be responsible for the behavioural phenotype and the increased Ca2+ activation observed in young adults. It is interesting to note that neuronal hyperactivation is thought to occur in the early stages of human AD, prior to the appearance of clinical symptoms [48].

Fig 7. Staining with X-34 does not reveal amyloid deposits in BAG-Aβ42 worms.

(A) BAG- Aβ42 animal grown until day 7 at 25°C followed by live staining with X-34. X-34 staining (blue) is observed diffusely throughout the body and at the mouth cavity (asterisk), but not observed to co-localise with the BAG neurons (red). (B) GMC101 animal overexpressing Aβ42 in the body wall muscle cells grown until day 7 at 25°C, showing deposits positive for X-34 (blue, deposits marked with arrows).


We have reported the creation and characterisation of a C. elegans model expressing human Aβ42 in the BAG neurons from a single gene copy. Whereas C. elegans models based on tissue-wide overexpression of Aβ tend to exhibit toxicity in terms of paralysis, shortened lifespan, chemotaxis and memory defects, our model appears to remain generally healthy. We did, however, find specific alterations of the behavioural responses mediated by the BAG neurons. These changes may reflect perturbations in neuronal signalling mediated by soluble Aβ42 species and which may be relevant to the early stages of AD. Alternatively, the ectopic expression of human Aβ42 may modulate synaptic transmission and plasticity in young C. elegans animals as part of its physiological role [49]. Overall, these results suggest that effective strategies to create animal models of Alzheimer’s disease could be developed by generating perturbations sufficient to modulate specific physiological responses, but not strong enough to cause directly more widespread toxicity processes. Subjecting such models to additional perturbations or forms of stress may be sufficient to trigger the disease process in a more physiological manner than in traditional overexpression models.

Supporting information

S1 Fig. Behavioural response of animals overexpressing Aβ42 in BAG in npr-1 background.

CO2 response of npr-1 animals overexpressing Aβ42 in BAG (red, n = 280) and non-transgenic siblings (blue, n = 89) in 7% O2 background.


S2 Fig. Behavioural response of the BAG-Aβ worms and N2 wild-type worms raised at 20°C.

A-C) The fractions of worms making omega turns in response to 3% CO2 (shaded in blue) at day 1 (A), day 2 (B) and day 4 (C) of adulthood. D-E) Speed response at day 1 (D), day 2 (E) and day 4 (F). The data represent 2–3 assays for each time point and strain from one biological replicate, Aβ n = 66 (day 1), n = 71 (day 2), n = 47 (day 4); N2 n = 46 (day 1), n = 66 (day 2), n = 65 (day 4).



We thank Dr Lorenz Fenk and Dr Changchun Chen for plasmids and assistance, Dr Mathias Pasche for help with confocal microscopy, the members of the De Bono group and the Cambridge Centre for Misfolding Diseases for valuable discussions, and the Caenorhabditis Genetics Center for strains.


  1. 1. Knowles TPJ, Vendruscolo M, Dobson CM. The amyloid state and its association with protein misfolding diseases. Nat Rev Mol Cell Biol. 2014;15: 384–396. pmid:24854788
  2. 2. Labbadia J, Morimoto RI. The biology of proteostasis in aging and disease. Annu Rev Biochem. 2015;84: 435–464. pmid:25784053
  3. 3. Hipp MS, Park S-H, Hartl FU. Proteostasis impairment in protein-misfolding and -aggregation diseases. Trends Cell Biol. Elsevier Ltd; 2014;24: 506–514. pmid:24946960
  4. 4. Chiti F, Dobson CM. Protein misfolding, amyloid formation, and human disease: a summary of progress over the last decade. Annu Rev Biochem. 2017;86: 27–68. pmid:28498720
  5. 5. Jack CR, Bennett DA, Blennow K, Carrillo MC, Feldman HH, Frisoni GB, et al. A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology. 2016;87: 539–547. pmid:27371494
  6. 6. Soto C. Protein misfolding in neurodegenerative diseases: the key pending questions. J Neurol Transl Neurosci. 2013;1: 19–22.
  7. 7. De Strooper B, Karran E. The cellular phase of Alzheimer’s disease. Cell. 2016;164: 603–615. pmid:26871627
  8. 8. Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O, et al. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer’s disease: A prospective cohort study. Lancet Neurol. 2013;12: 357–367. pmid:23477989
  9. 9. Bateman RJ, Xiong C, Benzinger TLS, Fagan AM, Goate A, Fox NC, et al. Clinical and biomarker changes in dominantly inherited Alzheimer’s disease. N Engl J Med. 2012;367: 795–804. pmid:22784036
  10. 10. Jack CR, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, et al. Tracking pathophysiological processes in Alzheimer’s disease: An updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013;12: 207–216. pmid:23332364
  11. 11. Palop JJ, Mucke L. Amyloid-beta-induced neuronal dysfunction in Alzheimer’s disease: from synapses toward neural networks. Nat Neurosci. 2010;13: 812–818. pmid:20581818
  12. 12. Spires-Jones TL, Hyman B. The intersection of amyloid beta and tau at synapses in Alzheimer’s Disease. Neuron. 2014;82: 756–771. pmid:24853936
  13. 13. Selkoe DJ. Alzheimer’s Disease is a synaptic failure. Science. 2002;298: 789–791. pmid:12399581
  14. 14. White JG, Southgate E, Thomson JN, Brenner S. The structure of the nervous system of the nematode Caenorhabditis elegans. Philos Trans R Soc B Biol Sci. 1986;314: 1–340. pmid:22462104
  15. 15. Ewald CY, Li C. Caenorhabditis elegans as a model organism to study APP function. Exp Brain Res. 2012;217: 397–411. pmid:22038715
  16. 16. Link CD. Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans. Proc Natl Acad Sci U S A. 1995;92: 9368–9372. pmid:7568134
  17. 17. McColl G, Roberts BR, Pukala TL, Kenche VB, Roberts CM, Link CD, et al. Utility of an improved model of amyloid-beta (Aβ1–42) toxicity in Caenorhabditis elegans for drug screening for Alzheimer’s disease. Mol Neurodegener. 2012;7: 1–9.
  18. 18. Khabirova E, Moloney A, Marciniak SJ, Williams J, Lomas DA, Oliver SG, et al. The TRiC/CCT chaperone is implicated in Alzheimer’s disease based on patient GWAS and an RNAi screen in Aβ-expressing Caenorhabditis elegans. PLoS One. 2014;9: 1–13. pmid:25080104
  19. 19. Brehme M, Voisine C, Rolland T, Wachi S, Soper JH, Zhu Y, et al. A chaperome subnetwork safeguards proteostasis in aging and neurodegenerative disease. Cell Rep. The Authors; 2014;9: 1–16. pmid:25437566
  20. 20. Habchi J, Arosio P, Perni M, Costa AR, Yagi-Utsumi M, Joshi P, et al. An anti-cancer drug suppresses the primary nucleation reaction that initiates the formation of toxic Aβ aggregates associated with Alzheimer’s disease. Sci Adv. 2016;e1501244: 1–13. pmid:26933687
  21. 21. Habchi J, Chia S, Limbocker R, Mannini B, Ahn M, Perni M, et al. Systematic development of small molecules to inhibit specific microscopic steps of Aβ42 aggregation in Alzheimer’s disease. Proc Natl Acad Sci U S A. 2016;114: E200–208. pmid:28011763
  22. 22. Wu Y, Wu Z, Butko P, Christen Y, Lambert MP, Klein WL, et al. Amyloid-beta-induced pathological behaviors are suppressed by Ginkgo biloba extract EGb 761 and ginkgolides in transgenic Caenorhabditis elegans. J Neurosci. 2006;26: 13102–13113. pmid:17167099
  23. 23. Dosanjh LE, Brown MK, Rao G, Link CD, Luo Y. Behavioral phenotyping of a transgenic Caenorhabditis elegans expressing neuronal amyloid-beta. J Alzheimer’s Dis. 2010;19: 681–690. pmid:20110612
  24. 24. Treusch S, Hamamichi S, Goodman JL, Matlack KES, Chung CY, Baru V, et al. Functional links between Abeta toxicity, endocytic trafficking, and Alzheimers Disease risk factors in yeast. Science. 2011;334: 1241–1245. pmid:22033521
  25. 25. Cotella D, Hernandez-Enriquez B, Wu X, Li R, Pan Z, Leveille J, et al. Toxic Role of K+ Channel Oxidation in Mammalian Brain. J Neurosci. 2012;32: 4133–4144. pmid:22442077
  26. 26. Mello CC, Kramer JM, Stinchcomb D, Ambros V. Efficient gene transfer in C.elegans: extrachromosomal maintenance and integration of transforming sequences. EMBO J. 1991;10: 3959–70. pmid:1935914
  27. 27. Francis PT. Glutamatergic systems in Alzheimer’s disease. Int J Geriatr Psychiatry. 2003;18: S15–S21. pmid:12973746
  28. 28. Esposito Z, Belli L, Toniolo S, Sancesario G, Bianconi C, Martorana A. Amyloid β, glutamate, excitotoxicity in alzheimer’s disease: Are we on the right track? CNS Neurosci Ther. 2013;19: 549–555. pmid:23593992
  29. 29. Revett TJ, Baker GB, Jhamandas J, Kar S. Glutamate system, amyloid-beta peptides and tau protein: Functional interrelationships and relevance to Alzheimer disease pathology. J Psychiatry Neurosci. 2013;38: 6–23. pmid:22894822
  30. 30. Fu H, Possenti A, Freer R, Nakano Y, Hernandez Villegas NC, Tang M, et al. A tau homeostasis signature is linked with the cellular and regional vulnerability of excitatory neurons to tau pathology. Nat Neurosci. 2019;22: 47–56. pmid:30559469
  31. 31. Roselli F, Caroni P. From intrinsic firing properties to selective neuronal vulnerability in neurodegenerative diseases. Neuron. 2015;85: 901–910. pmid:25741719
  32. 32. Bretscher AJ, Busch KE, de Bono M. A carbon dioxide avoidance behavior is integrated with responses to ambient oxygen and food in Caenorhabditis elegans. Proc Natl Acad Sci U S A. 2008;105: 8044–8049. pmid:18524954
  33. 33. Hallem EA, Sternberg PW. Acute carbon dioxide avoidance in Caenorhabditis elegans. Proc Natl Acad Sci U S A. 2008;105: 8038–8043. pmid:18524955
  34. 34. Hallem EA, Spencer WC, McWhirter RD, Zeller G, Henz SR, Rätsch G, et al. Receptor-type guanylate cyclase is required for carbon dioxide sensation by Caenorhabditis elegans. Proc Natl Acad Sci U S A. 2011;108: 254–9. pmid:21173231
  35. 35. Bretscher AJ, Kodama-Namba E, Busch KE, Murphy RJ, Soltesz Z, Laurent P, et al. Temperature, oxygen, and salt-sensing neurons in C. elegans are carbon dioxide sensors that control avoidance behavior. Neuron. 2011;69: 1099–1113. pmid:21435556
  36. 36. Fenk LA, de Bono M. Environmental CO2 inhibits Caenorhabditis elegans egg-laying by modulating olfactory neurons and evokes widespread changes in neural activity. Proc Natl Acad Sci U S A. 2015;112: E3525–E3534. pmid:26100886
  37. 37. Grote A, Hiller K, Scheer M, Münch R, Nörtemann B, Hempel DC, et al. JCat: A novel tool to adapt codon usage of a target gene to its potential expression host. Nucleic Acids Res. 2005;33: 526–531. pmid:15980527
  38. 38. Frokjaer-Jensen C, Davis MW, Sarov M, Taylor J, Flibotte S, LaBella M, et al. Random and targeted transgene insertion in C. elegans using a modified Mosl transposon. Nat Methods. 2014;11: 529–534. pmid:24820376
  39. 39. McIntire SL, Garriga G, White J, Jacobson D, Horvitz HR. Genes necessary for directed axonal elengation and fasciculation in Caenorhabditis elegans. Neuron. 1992;8: 307–322. pmid:1739461
  40. 40. Link CD, Silverman MA, Breen M, Watt KE, Dames SA. Characterization of Caenorhabditis elegans lectin-binding mutants. Genetics. 1992;131: 867–881. pmid:1516818
  41. 41. Perni M, Challa PK, Kirkegaard JB, Limbocker R, Koopman M, Hardenberg MC, et al. Massively parallel C. elegans tracking provides multi-dimensional fingerprints for phenotypic discovery. J Neurosci Methods. 2018;306: 57–67. pmid:29452179
  42. 42. Nagai T, Yamada S, Tominaga T, Ichikawa M, Miyawaki A. Expanded dynamic range of fluorescent indicators for Ca2+ by circularly permuted yellow fluorescent proteins. Proc Natl Acad Sci U S A. 2004;101: 10554–10559. pmid:15247428
  43. 43. Chen C, Itakura E, Nelson GM, Sheng M, Laurent P, Fenk LA, et al. IL-17 is a neuromodulator of Caenorhabditis elegans sensory responses. Nature. 2017;542: 43–48. pmid:28099418
  44. 44. Link CD, Johnson CJ, Fonte V, Paupard MC, Hall DH, Styren S, et al. Visualization of fibrillar amyloid deposits in living, transgenic Caenorhabditis elegans animals using the sensitive amyloid dye, X-34. Neurobiol Aging. 2001;22: 217–226. pmid:11182471
  45. 45. Zimmer M, Gray JM, Pokala N, Chang AJ, Karow DS, Marletta MA, et al. Neurons Detect Increases and Decreases in Oxygen Levels Using Distinct Guanylate Cyclases. Neuron. Elsevier Ltd; 2009;61: 865–879. pmid:19323996
  46. 46. Guillermin ML, Carrillo MA, Hallem EA, Kunkel M, McArdle C, Paz-y-Mino G, et al. A Single Set of Interneurons Drives Opposite Behaviors in C. elegans. Curr Biol. Elsevier Ltd.; 2017;104: 2283–2288. pmid:28823678
  47. 47. Herndon LA, Schmeissner PJ, Dudaronek JM, Brown PA, Listner KM, Sakano Y, et al. Stochastic and genetic factors influence tissue-specific decline in ageing C. elegans. Nature. 2002;419: 808–814. pmid:12397350
  48. 48. Palop JJ, Mucke L. Network abnormalities and interneuron dysfunction in Alzheimer disease. Nat Rev Neurosci. Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.; 2016;17: 777. Available: pmid:27829687
  49. 49. Rice HC, Malmazet D De, Schreurs A, Frere S, Molle I Van, Volkov AN, et al. Secreted amyloid-beta precursor protein functions as a GABABR1a ligand to modulate synaptic transmission. Science. 2019;363. pmid:30630900